Page last updated: 2024-09-04

ezetimibe and Blood Clot

ezetimibe has been researched along with Blood Clot in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antoku, Y; Egashira, K; Honda, K; Ichi, I; Koga, JI; Matoba, T; Nakano, K; Tsutsui, H1
Fazio, S; Weitz, JI1
Baigent, C; Blackwell, L; Emberson, J; Fellström, B; Haynes, R; Herrington, W; Hooi, LS; Landray, MJ; Levin, A; Massy, ZA; Reith, C; Staplin, N; Tesar, V; Walker, R1
Adamska, U; Adamski, P; Koziński, M; Kubica, J; Ostrowska, M1
Abela, GS; Abela, OG; Aziz, K; Berger, K; Janoudi, A; Patel, R; Rubinstein, J; Tamhane, U; Vedre, A1

Reviews

1 review(s) available for ezetimibe and Blood Clot

ArticleYear
New directions for pharmacotherapy in the treatment of acute coronary syndrome.
    Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:17

    Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Antibodies, Monoclonal; Anticholesteremic Agents; Clinical Trials as Topic; Drug Discovery; Ezetimibe; Humans; PCSK9 Inhibitors; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Thrombosis; Treatment Outcome

2016

Trials

1 trial(s) available for ezetimibe and Blood Clot

ArticleYear
The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection.
    Clinical journal of the American Society of Nephrology : CJASN, 2014, Volume: 9, Issue:5

    Topics: Aged; Anticholesteremic Agents; Azetidines; Catheterization; Cholesterol, LDL; Device Removal; Drug Therapy, Combination; Ezetimibe; Female; Humans; Male; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic; Reoperation; Simvastatin; Thrombosis; Vascular Access Devices; Vascular Patency

2014

Other Studies

3 other study(ies) available for ezetimibe and Blood Clot

ArticleYear
Lipid-Lowering Therapy With Ezetimibe Decreases Spontaneous Atherothrombotic Occlusions in a Rabbit Model of Plaque Erosion: A Role of Serum Oxysterols.
    Arteriosclerosis, thrombosis, and vascular biology, 2018, Volume: 38, Issue:4

    Topics: Angiotensin II; Animals; Anticholesteremic Agents; Arterial Occlusive Diseases; Atherosclerosis; Biomarkers; Cells, Cultured; Cholesterol, Dietary; Diet, High-Fat; Disease Models, Animal; Down-Regulation; Ezetimibe; Femoral Artery; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Oxysterols; Plaque, Atherosclerotic; Rabbits; Rats; Rosuvastatin Calcium; Signal Transduction; Thrombosis; Vascular System Injuries

2018
Overview of Therapeutic Approaches for Cholesterol Lowering and Attenuation of Thrombosis for Prevention of Atherothrombosis.
    Circulation research, 2019, Volume: 124, Issue:3

    Topics: Anticholesteremic Agents; Aspirin; Cholesterol, LDL; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; PCSK9 Inhibitors; Plaque, Atherosclerotic; Rivaroxaban; Thrombosis

2019
Plaque rupture and thrombosis are reduced by lowering cholesterol levels and crystallization with ezetimibe and are correlated with fluorodeoxyglucose positron emission tomography.
    Arteriosclerosis, thrombosis, and vascular biology, 2011, Volume: 31, Issue:9

    Topics: Animals; Anticholesteremic Agents; Aorta; Azetidines; C-Reactive Protein; Cholesterol; Crystallization; Ezetimibe; Fluorodeoxyglucose F18; Male; Plaque, Atherosclerotic; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Thrombosis

2011